|
AB Science Announces That FDA Authorization (IND) Has Been Granted for the …
MarketWatch (press release) For the record, severe persistent asthma uncontrolled with oral corticosteroids is a disease that has no registered treatment and all the immunosuppressant and biologic drugs tested to date have failed. Masitinib is therefore the only drug candidate in … |
View full post on asthma – Google News